NASDAQ
BYAH
Last Price
US $0.40
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Park Ha Biological Technology Co., Ltd. Ordinary Shares cash flow to debt ratio of 47.65% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's free cash flow has decreased -100.34% from $874.90K last year to $-2.97K, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's debt to equity ratio is 0.05, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's debt has increased relative to shareholder equity from 0.05 last year to 0.05 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Park Ha Biological Technology Co., Ltd. Ordinary Shares earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's profit margin has decreased (-4.28K%) in the last year from 20.09% to -840.65%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's short-term assets of $5.50M exceed its short-term liabilities of $1.88M
Decreasing performance - ROA.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's return on equity of -652.67%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Park Ha Biological Technology Co., Ltd. Ordinary Shares had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's yearly earnings has decreased -5.19K% since last year from $478.56K to $-24.36M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's yearly revenue has increased 6.00% since last year from $2.38M to $2.52M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -631.51% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Park Ha Biological Technology Co., Ltd. Ordinary Shares's 3-year revenue CAGR of 9.57% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Park Ha Biological Technology Co., Ltd. Ordinary Shares had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Park Ha Biological Technology Co., Ltd. Ordinary Shares had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Park Ha Biological Technology Co., Ltd. Ordinary Shares is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has a price-to-book ratio of 0.06x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Park Ha Biological Technology Co., Ltd. Ordinary Shares has a price-to-sales ratio of 0.08x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-652.67%
Return on equity
ROIC: -631.51%
Valuation History
-0.01X
Price to Earnings
EV/EBITDA: 0.12X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $0.40
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.